We evaluated the impact of an alpha-glucan extracted from maitake mushrooms on mice with a model of type 2 diabetes. This study specifically focused on various health markers related to liver function and diabetes.
By administering two different doses of the maitake mushroom extract, we observed significant improvements across several measures in diabetic mice. The treatment led to reductions in body weight, fasting blood sugar levels, and harmful substances like triglycerides and cholesterol.
Notably, we found that liver functions improved as evidenced by increased levels of beneficial substances like glycogen and reduced oxidative stress markers. Additionally, we observed enhanced insulin sensitivity, which is crucial for managing diabetes effectively.
These findings suggest that maitake mushrooms may offer tangible benefits not only for diabetes management but specifically for protecting and improving liver health in affected individuals.
Read More
We explored the effects of Uncaria tomentosa, commonly known as cat's claw, on non-alcoholic fatty liver disease (NAFLD) in two different models of obesity: mice on a high-fat diet and genetically obese mice. Both groups were experiencing insulin resistance, along with noticeable liver issues such as an excess of fat and inflammation.
The results were promising. Cat's claw treatment led to significant reductions in liver fat and inflammation across both mouse models. We observed that in the high-fat diet group, serine phosphorylation of the protein IRS-1 decreased by 25% with cat's claw treatment, which is a positive sign of enhanced insulin sensitivity.
Overall, we found that the cat's claw extract improved blood sugar control and helped to revert NAFLD to a healthier state, accompanied by reduced liver inflammation. This suggests a beneficial potential for cat's claw in tackling liver-related complications often associated with obesity.
Read More
We conducted a double-blinded, placebo-controlled clinical trial to explore how myo-inositol (MI) influences insulin resistance (IR) among obese individuals with non-alcoholic fatty liver disease (NAFLD). Our study involved 48 participants who were randomly assigned to receive either 4 grams of MI or a placebo daily for eight weeks.
Throughout this period, we measured various parameters such as weight, serum glucose levels, and insulin sensitivity indices before and after the intervention. Notably, we found that MI supplementation led to significant improvements in the expression levels of key genes related to the AMPK/PI3K/AKT signaling pathway, which plays a crucial role in regulating metabolism.
The results indicated noteworthy enhancements in insulin resistance for those who received MI, measured through multiple indices, reinforcing its potential benefits for liver health management. Thus, we observed that supplementing with myo-inositol not only bolstered the expression of important metabolic genes but also helped improve insulin resistance in our participants with NAFLD.
Read More
Maitake extract shows liver benefitsApplication of the thick extract from Maitake mushrooms for correction of metabolic disorders under the paracetamol hepatitis in rats.
Moderate relevance due to comparison
We explored the potential of Maitake mushroom extract as a treatment for liver disease, specifically in cases of paracetamol-induced hepatitis in rats. The study involved a controlled experiment with 60 male rats, split into groups to assess the effects of the mushroom extract against a comparison drug known as Silibor.
For the tests, rats were given a significant dose of acetaminophen to induce liver damage. This was followed by administering the thick extract of Maitake mushrooms to see if it could help mitigate the damage. We observed that the extract was given before and after the toxic treatment to evaluate its potential protective properties.
Our findings indicated that the Maitake mushroom extract showed promising effects by exhibiting hepatoprotective, cytoprotective, and antioxidative properties. This suggests that it may indeed offer a beneficial approach to supporting liver health during acute damage caused by toxins. While more research is necessary to understand its effectiveness fully, this study highlights the value of natural substances like Maitake mushrooms in liver disease treatment.
Read More
Maitake beneficial against liver cancerSynergistic Apoptotic Effect of D-Fraction From Grifola frondosa and Vitamin C on Hepatocellular Carcinoma SMMC-7721 Cells.
Mushroom's effects on liver cancer
We examined the effects of a combination of D-fraction polysaccharide from the maitake mushroom and vitamin C on liver cancer cells in a lab setting. The goal was to find out whether this mix could effectively reduce the growth of hepatocellular carcinoma, a common type of liver cancer.
Our experiments included various concentrations of the mushroom extract and vitamin C to test their anticancer properties against the SMMC-7721 liver cancer cell line. We discovered that when we combined 0.2 mg/mL of the D-fraction extract with 0.3 mmol/L of vitamin C, there was a notable 70% reduction in the cancer cells' viability.
Additionally, we found that about 65% of these cells underwent apoptosis, or programmed cell death, after treatment. This suggests that the combination not only halted the cancer cells' ability to divide but also pushed many of them toward self-destruction. Observations made using electron microscopy revealed significant changes in the cell structure following treatment, further supporting the effectiveness of this combination.
In our analysis of the mechanism behind these effects, we noted key protein changes that indicated the activation of the apoptosis process, showing that this combination may offer a promising avenue for future liver cancer therapies.
Read More